Phage Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.phagepharma.com
Safety Study of Topical Human FGF-1 for Wound Healing
Phase 1
- Conditions
- Diabetic Foot Ulcers
- Interventions
- Drug: FGF-1 141
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2012-03-12
- Lead Sponsor
- Phage Pharmaceuticals, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT00916292
- Locations
- 🇺🇸
Dedicated Phase I, Phoenix, Arizona, United States
Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency
Phase 1
Completed
- Conditions
- Growth Hormone Deficiency
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2012-03-12
- Lead Sponsor
- Phage Pharmaceuticals, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT00489294
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath